טוען...

Efficacy and safety of canagliflozin compared with placebo and sitagliptin in patients with type 2 diabetes on background metformin monotherapy: a randomised trial

AIMS/HYPOTHESIS: The aim of this work was to evaluate the efficacy and safety of canagliflozin vs placebo and sitagliptin in patients with type 2 diabetes who were being treated with background metformin. METHODS: This randomised, double-blind, four-arm, parallel-group, Phase 3 study was conducted a...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Lavalle-González, F. J., Januszewicz, A., Davidson, J., Tong, C., Qiu, R., Canovatchel, W., Meininger, G.
פורמט: Artigo
שפה:Inglês
יצא לאור: Springer Berlin Heidelberg 2013
נושאים:
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC3825495/
https://ncbi.nlm.nih.gov/pubmed/24026211
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00125-013-3039-1
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!